Mutant huntingtin represses CBP, but not p300, by binding and protein degradation

scientific journal article

Mutant huntingtin represses CBP, but not p300, by binding and protein degradation is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID16456924

P50authorGert-Jan van OmmenQ29643727
Raymund A. C. RoosQ67223099
Barry A PepersQ130285078
P2093author name stringBernd O. Evert
David C. Rubinsztein
Josephine C. Dorsman
Shu-Yan Cong
P433issue4
P304page(s)560–571
P577publication date2005-12-01
P1433published inMolecular and Cellular NeuroscienceQ6895985
P1476titleMutant huntingtin represses CBP, but not p300, by binding and protein degradation
P478volume30

Reverse relations

cites work (P2860)
Q38766912A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease.
Q38730380A mutant O-GlcNAcase enriches Drosophila developmental regulators.
Q37249167Acetyltransferases (HATs) as targets for neurological therapeutics
Q36767264Drug targeting of dysregulated transcription in Huntington's disease
Q36581367Early-onset sleep defects in Drosophila models of Huntington's disease reflect alterations of PKA/CREB signaling
Q28075559Epigenetic Changes in Neurodegenerative Diseases
Q34323841Epigenetic memory: the Lamarckian brain
Q37338808Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington's disease.
Q33457171Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6/2 mouse model of Huntington's disease
Q50072053Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones
Q43901692Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease
Q38085375Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders.
Q41600591Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease
Q27319481New striatal neurons in a mouse model of progressive striatal degeneration are generated in both the subventricular zone and the striatal parenchyma
Q35832677Pcaf modulates polyglutamine pathology in a Drosophila model of Huntington's disease.
Q40111505Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons.
Q39124557Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease
Q38019159Targeting Huntington's disease through histone deacetylases
Q37774037Targeting histone deacetylases for the treatment of Huntington's disease.
Q35024695Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective

Search more.